Research
My research interests include pharmacoepidemiology, electronic health records and data linkage, cardiovascular risk management, and vascular biomechanics.
I am currently using linked routine primary and secondary care data in a number of ways to examine prescribing practices, in addition to investigating the use of these data for the purposes of quantifying multiple morbidity.
Publications
Response to: assessing the harms of polypharmacy requires careful interpretation and consistent definitions. Payne RA, Abel GA, Avery AJ, Mercer SW, Roland MO. Br J Clin Pharmacol. 2014 Sep;78(3):672-3.
How Do People With Diabetes Describe Their Experiences in Primary Care? Evidence From 85,760 Patients With Self-Reported Diabetes From the English General Practice Patient Survey. Paddison CA, Saunders CL, Abel GA, Payne RA, Adler AI, Graffy JP, Roland MO. Diabetes Care. 2014 Sep 30.
Cardiovascular polypharmacy is not associated with unplanned hospitalisation: evidence from a retrospective cohort study. Appleton SC, Abel GA, Payne RA. BMC Fam Pract. 2014 Mar 31;15:58.
Prevalence of polypharmacy in a Scottish primary care population. Payne RA, Avery AJ, Duerden M, Saunders CL, Simpson CR, Abel GA. Eur J Clin Pharmacol. 2014 May;70(5):575-81.
Is polypharmacy always hazardous? A retrospective cohort analysis using linked electronic health records from primary and secondary care. Payne RA, Abel GA, Avery AJ, Mercer SW, Roland MO. Br J Clin Pharmacol. 2014 Jun;77(6):1073-82.
Letter by Payne and Webb regarding article, "agreement among cardiovascular disease risk calculators". Payne RA, Webb DJ. Circulation. 2013 Nov 19;128(21):e428.
ACE inhibitor and angiotensin receptor-II antagonist prescribing and hospital admissions with acute kidney injury: a longitudinal ecological study. Tomlinson LA, Abel GA, Chaudhry AN, Tomson CR, Wilkinson IB, Roland MO, Payne RA. PLoS One. 2013 Nov 6;8(11):e78465.
